பிராண்டன் மூலதனம் கூட்டாளர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிராண்டன் மூலதனம் கூட்டாளர்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிராண்டன் மூலதனம் கூட்டாளர்கள் Today - Breaking & Trending Today

VC Daily: Venture Capitalists Push Back Against Drug-Pricing Bill

VC Daily: Venture Capitalists Push Back Against Drug-Pricing Bill
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

New South Wales , United Kingdom , Al Iskandariyah , United States , City Of , Noord Holland , Walnut Creek , Santa Monica , North Lanarkshire , Maple Grove , Vanqua Bio , Wouter Verhoeven , Peter Kolchinsky , Arjun Goyal , Chan Lee , Chris Dattaro , Lina Khan , Andreessen Horowitz , Jim Trenkle , Aspen Rxhealth , Jesse Hall , Roche Genentech , Karen Walker , John Stanford , Keno Gutierrez , Chris Cumming ,

George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director


George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director
2021
- George Medicines, a late-stage drug development company focused on providing innovative and accessible medicines for the world s leading causes of death, today announces the appointment of Dr Charmaine Gittleson to the Board as Independent Non-Executive Director.
Dr Gittleson has extensive international experience as a pharmaceutical physician and enterprise leader. Prior to joining the Board of George Medicines, Dr Gittleson worked at global ASX-listed specialty biotechnology company CSL Behring, where she most recently held the role of Chief Medical Officer. During her 15-year tenure at the company, she held various senior roles in clinical research, medical safety, medical and patient-related ethics, strategic product development, planning and implementation across multiple therapeutic and rare disease areas. ....

South Africa , United Kingdom , City Of , Allison Connolly , David Daley , Kostenloser Wertpapierhandel , Stephen Macmahon , Lindsey Neville , Charmaine Gittleson , Australian Institute Of Company Directors , Australian Medical Council Qualification , George Health , Drug Administration , George Institute For Global Health , Stanford University Company Directors Course , George Institute , University Of Witwatersrand , Consilium Strategic Communications , George Medicines , Independent Non Executive , Chief Medical , Australian Institute , Company Directors , Stanford University , Chairmanof George Medicines , Non Executive Director ,

$14m invested in world-leading RNA therapy: University of Otago spinout targeting new cancer treatments


Date Time
$14m invested in world-leading RNA therapy: University of Otago spinout targeting new cancer treatments
Amaroq Therapeutics, a new biotech start-up spun out of the University of Otago, with one of the world’s most advanced programs in next-generation RNA therapy to target cancer has secured NZ$14m investment to accelerate development.
Dr Sarah Diermeier.
The study of long non-coding RNAs (lncRNAs), often referred to as “dark matter” of the genome, are molecules naturally present in cells. Acting as key cell regulators despite not coding for proteins they have become one of the hottest areas of research globally. The emergence of new sequencing technologies has provided the opportunity to research these molecules further with significant investments being made globally into companies focusing on this area. ....

New York , United States , New Zealand , David Christensen , Sarah Diermeier , David Spector , Duncan Mackintosh , University Of Otago , Research Commercialisation Fund , Cold Spring Harbor Laboratory New York , Callaghan Innovation Technology Incubator Programme , Otago Innovation Ltd , Amaroq Therapeutics , Chief Scientific Officer , Brandon Capital , Cure Kids , Callaghan Innovation Repayable Grant , Callaghan Innovation Technology Incubator , Professor David Spector , Cold Spring Harbor Laboratory , Rutherford Discovery Fellow , Otago Innovation , Through Amaroq , Brandon Capital Managed , Medical Research Commercialisation Fund , Brandon Capital Partners ,